Literature DB >> 21900752

MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity.

Maren H Stindt1, Stephanie Carter, Arnaud M Vigneron, Kevin M Ryan, Karen H Vousden.   

Abstract

The tumor suppressor p53 is extensively regulated by post-translational modification, including modification by the small ubiquitin-related modifier SUMO. We show here that MDM2, previously shown to promote ubiquitin, Nedd8 and SUMO-1 modification of p53, can also enhance conjugation of endogenous SUMO-2/3 to p53. Sumoylation activity requires p53-MDM2 binding but does not depend on an intact RING finger. Both ARF and L11 can promote SUMO-2/3 conjugation of p53. However, unlike the previously described SUMO-1 conjugation of p53 by an MDM2-ARF complex, this activity does not depend on the ability of MDM2 to relocalize to the nucleolus. Interestingly, the SUMO consensus is not conserved in mouse p53, which is therefore not modified by SUMO-2/3. Finally, we show that conjugation of SUMO-2/3 to p53 correlates with a reduction of both activation and repression of a subset of p53-target genes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21900752      PMCID: PMC3218624          DOI: 10.4161/cc.10.18.17436

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  89 in total

1.  p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor.

Authors:  J Yun; H D Chae; H E Choy; J Chung; H S Yoo; M H Han; D Y Shin
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

2.  Mdm2 binds p73 alpha without targeting degradation.

Authors:  E Bálint; S Bates; K H Vousden
Journal:  Oncogene       Date:  1999-07-08       Impact factor: 9.867

3.  MDM2 interacts with MDMX through their RING finger domains.

Authors:  S Tanimura; S Ohtsuka; K Mitsui; K Shirouzu; A Yoshimura; M Ohtsubo
Journal:  FEBS Lett       Date:  1999-03-19       Impact factor: 4.124

4.  Distinct in vivo dynamics of vertebrate SUMO paralogues.

Authors:  Ferhan Ayaydin; Mary Dasso
Journal:  Mol Biol Cell       Date:  2004-09-29       Impact factor: 4.138

5.  Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.

Authors:  Carol Imbriano; Aymone Gurtner; Fabienne Cocchiarella; Silvia Di Agostino; Valentina Basile; Monica Gostissa; Matthias Dobbelstein; Giannino Del Sal; Giulia Piaggio; Roberto Mantovani
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

6.  Ubch9 conjugates SUMO but not ubiquitin.

Authors:  J M Desterro; J Thomson; R T Hay
Journal:  FEBS Lett       Date:  1997-11-17       Impact factor: 4.124

7.  Analysis of the degradation function of Mdm2.

Authors:  M H Kubbutat; R L Ludwig; A J Levine; K H Vousden
Journal:  Cell Growth Differ       Date:  1999-02

8.  The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

Authors:  F J Stott; S Bates; M C James; B B McConnell; M Starborg; S Brookes; I Palmero; K Ryan; E Hara; K H Vousden; G Peters
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

9.  Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.

Authors:  R Honda; H Yasuda
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

10.  Comparative study of the p53-mdm2 and p53-MDMX interfaces.

Authors:  V Böttger; A Böttger; C Garcia-Echeverria; Y F Ramos; A J van der Eb; A G Jochemsen; D P Lane
Journal:  Oncogene       Date:  1999-01-07       Impact factor: 9.867

View more
  23 in total

1.  SUMOylation of p53 mediates interferon activities.

Authors:  Laura Marcos-Villar; José V Pérez-Girón; Jéssica M Vilas; Atenea Soto; Carlos F de la Cruz-Hererra; Valerie Lang; Manuel Collado; Anxo Vidal; Manuel S Rodríguez; César Muñoz-Fontela; Carmen Rivas
Journal:  Cell Cycle       Date:  2013-08-05       Impact factor: 4.534

2.  E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.

Authors:  Christopher T Coey; Megan E Fitzgerald; Atanu Maiti; Katherine H Reiter; Catherine M Guzzo; Michael J Matunis; Alexander C Drohat
Journal:  J Biol Chem       Date:  2014-04-21       Impact factor: 5.157

3.  High-level SAE2 promotes malignant phenotype and predicts outcome in gastric cancer.

Authors:  Duan-Fang Shao; Xiao-Hong Wang; Zi-Yu Li; Xiao-Fang Xing; Xiao-Jing Cheng; Ting Guo; Hong Du; Ying Hu; Bin Dong; Ning Ding; Lin Li; Shen Li; Qing-Da Li; Xian-Zi Wen; Lian-Hai Zhang; Jia-Fu Ji
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

4.  Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes.

Authors:  Che-Pei Kung; Sakina Khaku; Matthew Jennis; Yan Zhou; Maureen E Murphy
Journal:  Mol Cancer Res       Date:  2014-09-25       Impact factor: 5.852

5.  The RAX/PACT-PKR stress response pathway promotes p53 sumoylation and activation, leading to G₁ arrest.

Authors:  Richard L Bennett; Yu Pan; Jaime Christian; Teng Hui; W Stratford May
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

6.  DJ-1 protects the heart against ischemia-reperfusion injury by regulating mitochondrial fission.

Authors:  Yuuki Shimizu; Jonathan P Lambert; Chad K Nicholson; Joshua J Kim; David W Wolfson; Hee Cheol Cho; Ahsan Husain; Nawazish Naqvi; Li-Shen Chin; Lian Li; John W Calvert
Journal:  J Mol Cell Cardiol       Date:  2016-04-22       Impact factor: 5.000

7.  High-level SAE2 promotes malignant phenotype and predicts outcome in gastric cancer.

Authors:  Duan-Fang Shao; Xiao-Hong Wang; Zi-Yu Li; Xiao-Fang Xing; Xiao-Jing Cheng; Ting Guo; Hong Du; Ying Hu; Bin Dong; Ning Ding; Lin Li; Shen Li; Qing-Da Li; Xian-Zi Wen; Lian-Hai Zhang; Jia-Fu Ji
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

Review 8.  Role of base excision repair in maintaining the genetic and epigenetic integrity of CpG sites.

Authors:  Alfonso Bellacosa; Alexander C Drohat
Journal:  DNA Repair (Amst)       Date:  2015-05-01

9.  Nuclear interactor of ARF and Mdm2 regulates multiple pathways to activate p53.

Authors:  Sara M Reed; Jussara Hagen; Van S Tompkins; Katie Thies; Frederick W Quelle; Dawn E Quelle
Journal:  Cell Cycle       Date:  2014-02-19       Impact factor: 4.534

Review 10.  SUMO and Parkinson's disease.

Authors:  Katrin Eckermann
Journal:  Neuromolecular Med       Date:  2013-08-25       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.